World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
50119
World Ranking
14343
National Ranking
7250

Overview

Hikmat Al-Ahmadie is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily covers fields such as Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Surgery, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, and Cancer Research as subfields.

The scientist's work extensively addresses topics including Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Ferroptosis and cancer prognosis, and Urological Disorders and Treatments.

Hikmat Al-Ahmadie has contributed to several recent papers published in high-impact journals. Notable works include:

  • The repertoire of mutational signatures in human cancer, 2020, Nature
  • Pan-cancer analysis of whole genomes, 2020, Nature
  • Patterns of somatic structural variation in human cancer genomes, 2020, Nature
  • Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing, 2020, Nature Genetics
  • Comprehensive molecular characterization of mitochondrial genomes in human cancers, 2020, Nature Genetics

Their publication record includes frequent contributions to distinguished venues such as the Journal of Clinical Oncology, The Journal of Urology, Nature Communications, Cancer Research, and Clinical Cancer Research, reflecting a broad engagement with oncology and related medical research communities.

Hikmat Al-Ahmadie collaborates regularly with several researchers in the field, including David B. Solit, Eugene J. Pietzak, Bernard H. Bochner, Gopa Iyer, and Jonathan E. Rosenberg. These collaborations have resulted in numerous co-authored studies contributing to various aspects of cancer research and clinical oncology.

Best Publications

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Ahmet Zehir;Ryma Benayed;Ronak H Shah;Aijazuddin Syed

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Genome Sequencing Identifies a Basis for Everolimus Sensitivity

    Gopa Iyer;Gopa Iyer;Aphrothiti J. Hanrahan;Matthew Ivan Milowsky;Matthew Ivan Milowsky;Hikmat Al-Ahmadie

  • Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

    Suk Hyung Lee;Wenhuo Hu;Justin T. Matulay;Mark V. Silva

  • Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    Eliezer M Van Allen;Kent W. Mouw;Philip Kim;Gopa Iyer

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

    Xingxing Zang;R. Houston Thompson;Hikmat A. Al-Ahmadie;Hikmat A. Al-Ahmadie;Angel M. Serio

  • Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Min Yuen Teo;Kenneth Seier;Irina Ostrovnaya;Ashley M. Regazzi

  • Mitochondrial DNA copy number variation across human cancers

    Ed Reznik;Martin Lee Miller;Yasin Şenbabaoğlu;Nadeem Riaz

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • The role of SPINK1 in ETS rearrangement-negative prostate cancers.

    Scott A. Tomlins;Daniel R. Rhodes;Jianjun Yu;Sooryanarayana Varambally

Frequent Co-Authors

David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Satish K. Tickoo
Satish K. Tickoo Memorial Sloan Kettering Cancer Center
Nikolaus Schultz
Nikolaus Schultz Memorial Sloan Kettering Cancer Center
Maria E. Arcila
Maria E. Arcila Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can expand your career options beyond traditional medical school paths. Online programs now offer flexible routes into nursing, healthcare administration, nutrition, and more—particularly useful for working professionals or those seeking career advancement without relocating.

For registered nurses aiming to become Family Nurse Practitioners, adn to fnp programs provide accelerated bridge pathways from an Associate Degree in Nursing (ADN) to a Master of Science in Nursing (MSN). These programs allow you to build on existing experience and move quickly into advanced roles.

Students interested in nutrition and preventive health can consider enrolling in one of the best online nutrition programs. These degrees blend science coursework with practical skills, preparing graduates for careers in wellness, education, and clinical nutrition.

Administrative leadership is another growing field. Accredited online Master of Health Administration degrees, like the best mha programs, equip graduates with management, policy, and organizational skills to run healthcare facilities efficiently.

Lastly, those with an RN license may want options like an rn to bsn with no clinicals program. These degrees offer a streamlined way to earn a Bachelor of Science in Nursing and advance professionally, often without the requirement for additional clinical hours.

Best Scientists Citing Hikmat Al-Ahmadie

Trending Scientists